Breast Cancer Screening Benefits More Consistent Than Previously Thought

Article

Major studies looking at breast cancer screening with mammography may have more consistent findings than previously thought.

Major studies looking at breast cancer screening with mammography may have more consistent findings than previously thought. Robert A. Smith, PhD, of the American Cancer Society and colleagues re-examined data with common denominators and found interesting results.

Recent Videos
Findings from the OVARIO study show that patients with HRR–deficient and BRCA-mutated disease benefitted the most from niraparib/bevacizumab maintenance.
Select comorbidities, ECOG status, and the receipt of radiation were among the differences between a real-world cohort and the RUBY trial population.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight the many advantages to attending the 42nd Annual Miami Breast Cancer Conference, with some additional tidbits to round out the main event.
Other ongoing urothelial cancer trials are assessing enfortumab vedotin–based combinations in the neoadjuvant setting.
Related Content